281 related articles for article (PubMed ID: 32541026)
1. Macrophage metabolic reprogramming presents a therapeutic target in lupus nephritis.
Jing C; Castro-Dopico T; Richoz N; Tuong ZK; Ferdinand JR; Lok LSC; Loudon KW; Banham GD; Mathews RJ; Cader Z; Fitzpatrick S; Bashant KR; Kaplan MJ; Kaser A; Johnson RS; Murphy MP; Siegel RM; Clatworthy MR
Proc Natl Acad Sci U S A; 2020 Jun; 117(26):15160-15171. PubMed ID: 32541026
[TBL] [Abstract][Full Text] [Related]
2. Distinct pathogenic roles for resident and monocyte-derived macrophages in lupus nephritis.
Richoz N; Tuong ZK; Loudon KW; Patiño-Martínez E; Ferdinand JR; Portet A; Bashant KR; Thevenon E; Rucci F; Hoyler T; Junt T; Kaplan MJ; Siegel RM; Clatworthy MR
JCI Insight; 2022 Nov; 7(21):. PubMed ID: 36345939
[TBL] [Abstract][Full Text] [Related]
3. Dysregulated Fcγ receptor IIa-induced cytokine production in dendritic cells of lupus nephritis patients.
Newling M; Fiechter RH; Sritharan L; Hoepel W; van Burgsteden JA; Hak AE; van Vollenhoven RF; van de Sande MGH; Baeten DLP; den Dunnen J
Clin Exp Immunol; 2020 Jan; 199(1):39-49. PubMed ID: 31509231
[TBL] [Abstract][Full Text] [Related]
4. Sialylated Autoantigen-Reactive IgG Antibodies Attenuate Disease Development in Autoimmune Mouse Models of Lupus Nephritis and Rheumatoid Arthritis.
Bartsch YC; Rahmöller J; Mertes MMM; Eiglmeier S; Lorenz FKM; Stoehr AD; Braumann D; Lorenz AK; Winkler A; Lilienthal GM; Petry J; Hobusch J; Steinhaus M; Hess C; Holecska V; Schoen CT; Oefner CM; Leliavski A; Blanchard V; Ehlers M
Front Immunol; 2018; 9():1183. PubMed ID: 29928274
[TBL] [Abstract][Full Text] [Related]
5. Macrophage depletion ameliorates nephritis induced by pathogenic antibodies.
Chalmers SA; Chitu V; Herlitz LC; Sahu R; Stanley ER; Putterman C
J Autoimmun; 2015 Feb; 57():42-52. PubMed ID: 25554644
[TBL] [Abstract][Full Text] [Related]
6. DNA-dependent activator of interferon-regulatory factors (DAI) promotes lupus nephritis by activating the calcium pathway.
Zhang W; Zhou Q; Xu W; Cai Y; Yin Z; Gao X; Xiong S
J Biol Chem; 2013 May; 288(19):13534-50. PubMed ID: 23553627
[TBL] [Abstract][Full Text] [Related]
7. STING regulates metabolic reprogramming in macrophages via HIF-1α during Brucella infection.
Gomes MTR; Guimarães ES; Marinho FV; Macedo I; Aguiar ERGR; Barber GN; Moraes-Vieira PMM; Alves-Filho JC; Oliveira SC
PLoS Pathog; 2021 May; 17(5):e1009597. PubMed ID: 33989349
[TBL] [Abstract][Full Text] [Related]
8. Endogenous interleukin (IL)-17A promotes pristane-induced systemic autoimmunity and lupus nephritis induced by pristane.
Summers SA; Odobasic D; Khouri MB; Steinmetz OM; Yang Y; Holdsworth SR; Kitching AR
Clin Exp Immunol; 2014 Jun; 176(3):341-50. PubMed ID: 24528105
[TBL] [Abstract][Full Text] [Related]
9. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
Steinmetz OM; Turner JE; Paust HJ; Lindner M; Peters A; Heiss K; Velden J; Hopfer H; Fehr S; Krieger T; Meyer-Schwesinger C; Meyer TN; Helmchen U; Mittrücker HW; Stahl RA; Panzer U
J Immunol; 2009 Oct; 183(7):4693-704. PubMed ID: 19734217
[TBL] [Abstract][Full Text] [Related]
10. IL-34-Dependent Intrarenal and Systemic Mechanisms Promote Lupus Nephritis in MRL-
Wada Y; Gonzalez-Sanchez HM; Weinmann-Menke J; Iwata Y; Ajay AK; Meineck M; Kelley VR
J Am Soc Nephrol; 2019 Feb; 30(2):244-259. PubMed ID: 30622154
[TBL] [Abstract][Full Text] [Related]
11. Lentivirus-mediated knockdown of FcγRI (CD64) attenuated lupus nephritis via inhibition of NF-κB regulating NLRP3 inflammasome activation in MRL/lpr mice.
Zhang H; Liu L; Li L
J Pharmacol Sci; 2018 Aug; 137(4):342-349. PubMed ID: 30190171
[TBL] [Abstract][Full Text] [Related]
12. Syk Inhibitor Attenuates Polymicrobial Sepsis in FcgRIIb-Deficient Lupus Mouse Model, the Impact of Lupus Characteristics in Sepsis.
Issara-Amphorn J; Chancharoenthana W; Visitchanakun P; Leelahavanichkul A
J Innate Immun; 2020; 12(6):461-479. PubMed ID: 32927460
[TBL] [Abstract][Full Text] [Related]
13. TWEAK/Fn14 interactions are instrumental in the pathogenesis of nephritis in the chronic graft-versus-host model of systemic lupus erythematosus.
Zhao Z; Burkly LC; Campbell S; Schwartz N; Molano A; Choudhury A; Eisenberg RA; Michaelson JS; Putterman C
J Immunol; 2007 Dec; 179(11):7949-58. PubMed ID: 18025243
[TBL] [Abstract][Full Text] [Related]
14. Enhanced glycolysis and HIF-1α activation in adipose tissue macrophages sustains local and systemic interleukin-1β production in obesity.
Sharma M; Boytard L; Hadi T; Koelwyn G; Simon R; Ouimet M; Seifert L; Spiro W; Yan B; Hutchison S; Fisher EA; Ramasamy R; Ramkhelawon B; Moore KJ
Sci Rep; 2020 Mar; 10(1):5555. PubMed ID: 32221369
[TBL] [Abstract][Full Text] [Related]
15. Different amplifying mechanisms of interleukin-17 and interferon-gamma in Fcgamma receptor-mediated cartilage destruction in murine immune complex-mediated arthritis.
Grevers LC; van Lent PL; Koenders MI; Walgreen B; Sloetjes AW; Nimmerjahn F; Sjef Verbeek J; van den Berg WB
Arthritis Rheum; 2009 Feb; 60(2):396-407. PubMed ID: 19180490
[TBL] [Abstract][Full Text] [Related]
16. Blockade of macrophage autophagy ameliorates activated lymphocytes-derived DNA induced murine lupus possibly via inhibition of proinflammatory cytokine production.
Li B; Yue Y; Dong C; Shi Y; Xiong S
Clin Exp Rheumatol; 2014; 32(5):705-14. PubMed ID: 25151985
[TBL] [Abstract][Full Text] [Related]
17. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
[TBL] [Abstract][Full Text] [Related]
18. (5R)-5-hydroxytriptolide ameliorates lupus nephritis in MRL/
Zhang LY; Li H; Wu YW; Cheng L; Yan YX; Yang XQ; Zhu FH; He SJ; Tang W; Zuo JP
Am J Physiol Renal Physiol; 2017 Apr; 312(4):F769-F777. PubMed ID: 28100505
[TBL] [Abstract][Full Text] [Related]
19. Bromodomain Inhibitors Modulate FcγR-Mediated Mononuclear Phagocyte Activation and Chemotaxis.
Banham GD; Lee CYC; Ferdinand JR; Matthews RJ; Jing C; Smithers N; Prinjha RK; Clatworthy MR
Front Immunol; 2022; 13():885101. PubMed ID: 35619690
[TBL] [Abstract][Full Text] [Related]
20. Unique metabolic activation of adipose tissue macrophages in obesity promotes inflammatory responses.
Boutens L; Hooiveld GJ; Dhingra S; Cramer RA; Netea MG; Stienstra R
Diabetologia; 2018 Apr; 61(4):942-953. PubMed ID: 29333574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
